Monday, 15 Oct 2018

Bangla Version

Daily aspirin use may cut digestive cancer risk

No icon Pharmaceuticals

Health Desk: Nov 01, 2017: A study involving over 600,000 people finds, individuals who regularly use pain reliever aspirin are likely to experience a significant reduction in digestive cancer risk.

The findings showed that patients who were prescribed aspirin daily showed a 47 per cent reduction in liver and oesophageal cancer incidence.

Gastric cancer reduced by 38 per cent, pancreatic cancer by 34 per cent while colorectal cancer by 24 per cent, it said.

Digestive cancers account for almost a quarter of cancer cases in Europe.

Colorectal, gastric and pancreatic cancer are within the top five cancer killers throughout the continent, with digestive cancers representing 30.1 per cent of cancer deaths.

“The findings demonstrate that the long-term use of aspirin can reduce the risk of developing many major cancers,” said lead researcher Kelvin Tsoi, Professor at the Chinese University of Hong Kong.

The results were presented at the 25th United European Gastroenterology Week in Barcelona.